These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22693447)

  • 1. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.
    Bar KJ; Tsao CY; Iyer SS; Decker JM; Yang Y; Bonsignori M; Chen X; Hwang KK; Montefiori DC; Liao HX; Hraber P; Fischer W; Li H; Wang S; Sterrett S; Keele BF; Ganusov VV; Perelson AS; Korber BT; Georgiev I; McLellan JS; Pavlicek JW; Gao F; Haynes BF; Hahn BH; Kwong PD; Shaw GM
    PLoS Pathog; 2012; 8(5):e1002721. PubMed ID: 22693447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
    Rong R; Li B; Lynch RM; Haaland RE; Murphy MK; Mulenga J; Allen SA; Pinter A; Shaw GM; Hunter E; Robinson JE; Gnanakaran S; Derdeyn CA
    PLoS Pathog; 2009 Sep; 5(9):e1000594. PubMed ID: 19763269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
    Murphy MK; Yue L; Pan R; Boliar S; Sethi A; Tian J; Pfafferot K; Karita E; Allen SA; Cormier E; Goepfert PA; Borrow P; Robinson JE; Gnanakaran S; Hunter E; Kong XP; Derdeyn CA
    PLoS Pathog; 2013 Feb; 9(2):e1003173. PubMed ID: 23468623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.
    Lynch RM; Wong P; Tran L; O'Dell S; Nason MC; Li Y; Wu X; Mascola JR
    J Virol; 2015 Apr; 89(8):4201-13. PubMed ID: 25631091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.
    Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
    Moore PL; Ranchobe N; Lambson BE; Gray ES; Cave E; Abrahams MR; Bandawe G; Mlisana K; Abdool Karim SS; Williamson C; Morris L; ;
    PLoS Pathog; 2009 Sep; 5(9):e1000598. PubMed ID: 19763271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.
    Silver ZA; Dickinson GM; Seaman MS; Desrosiers RC
    J Virol; 2019 May; 93(10):. PubMed ID: 30842322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune escape mutations selected by neutralizing antibodies in natural HIV-1 infection can alter coreceptor usage repertoire of the transmitted/founder virus.
    Marichannegowda MH; Song H
    Virology; 2022 Mar; 568():72-76. PubMed ID: 35144109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
    Mielke D; Bandawe G; Pollara J; Abrahams MR; Nyanhete T; Moore PL; Thebus R; Yates NL; Kappes JC; Ochsenbauer C; Garrett N; Abdool Karim S; Tomaras GD; Montefiori D; Morris L; Ferrari G; Williamson C
    Front Immunol; 2019; 10():2875. PubMed ID: 31921139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
    Davis KL; Gray ES; Moore PL; Decker JM; Salomon A; Montefiori DC; Graham BS; Keefer MC; Pinter A; Morris L; Hahn BH; Shaw GM
    Virology; 2009 May; 387(2):414-26. PubMed ID: 19298995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.
    Anthony C; York T; Bekker V; Matten D; Selhorst P; Ferreria RC; Garrett NJ; Karim SSA; Morris L; Wood NT; Moore PL; Williamson C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    Wibmer CK; Gorman J; Ozorowski G; Bhiman JN; Sheward DJ; Elliott DH; Rouelle J; Smira A; Joyce MG; Ndabambi N; Druz A; Asokan M; Burton DR; Connors M; Abdool Karim SS; Mascola JR; Robinson JE; Ward AB; Williamson C; Kwong PD; Morris L; Moore PL
    PLoS Pathog; 2017 Jan; 13(1):e1006074. PubMed ID: 28076415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.
    Monini P; Cafaro A; Srivastava IK; Moretti S; Sharma VA; Andreini C; Chiozzini C; Ferrantelli F; Cossut MR; Tripiciano A; Nappi F; Longo O; Bellino S; Picconi O; Fanales-Belasio E; Borsetti A; Toschi E; Schiavoni I; Bacigalupo I; Kan E; Sernicola L; Maggiorella MT; Montin K; Porcu M; Leone P; Leone P; Collacchi B; Palladino C; Ridolfi B; Falchi M; Macchia I; Ulmer JB; Buttò S; Sgadari C; Magnani M; Federico MP; Titti F; Banci L; Dallocchio F; Rappuoli R; Ensoli F; Barnett SW; Garaci E; Ensoli B
    PLoS One; 2012; 7(11):e48781. PubMed ID: 23152803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
    Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
    PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody.
    Dingens AS; Haddox HK; Overbaugh J; Bloom JD
    Cell Host Microbe; 2017 Jun; 21(6):777-787.e4. PubMed ID: 28579254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.